WASHINGTON — Senior administration officials are promising that Friday afternoon, President Trump will roll out “the most comprehensive plan to tackle prescription drug affordability of any president.”
But ahead of his 2 p.m. remarks, the White House is keeping the actual plans under wraps — only hinting at the kinds of new policies that might come out in a “blueprint,” to be released alongside the speech and entitled “American Patients First.” In a late Thursday call with reporters, two senior administration officials largely deflected questions about exactly what’s to come in that blueprint, or in a separate “request for information” — an early regulatory outline of proposals — that will also accompany the remarks.
The only specific detail the administration officials would share: the plan will not include a call for Congress to allow Medicare to negotiate drug prices, a policy long favored by many progressive lawmakers and drug price reform advocates. Such negotiations are currently barred by federal law.
About the Author Reprints
Potus just got bought. Talk is cheap but walk is not. Medicare drug prices need to be negotiated.
May be generics should with Amazon take control.
Improving Drug Affordability for the United States Populous through Alternate Business Models
https://pharmachemicalscoatings.blogspot.com/2018/05/improving-drug-affordability-for-united.html?m=1
The bar is pretty low as regards to previous presidents.